MedicarePartD.guide

A non-government resource built from CMS public data

Qulipta on SilverScript Choice (S5601-004)

atogepant

Covered, with prior authorization required.

Tier 3 (preferred brand). Quantity limit of 30 per 30 days.

$230.67
Patient pays / month, after deductible
$728.82
Patient pays / month, before the $615.00 deductible
$692.02
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

QULIPTA 10 mg Tablet at a preferred retail pharmacy, from the plan's negotiated price of $1,214.07 for a month. Other covered strengths are listed below.

Prior authRequired on all 3 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 3 covered strengths and forms
FormTierPatient pays / monthLimits
QULIPTA 60 mg Tablet3$230.68PA · 30 per 30 days
QULIPTA 10 mg Tablet3$230.67PA · 30 per 30 days
QULIPTA 30 mg Tablet3$230.70PA · 30 per 30 days

Other CGRP migraine drugs on this plan

Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5601-004